CUSIP: 922042858
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / FTSE EMR MKT ETF
-
Total 13F shares
-
587,739,064
-
Share change
-
-2,740,799
-
Total reported value
-
$20,322,484,788
-
Put/Call ratio
-
70%
-
Price per share
-
$34.58
-
Number of holders
-
884
-
Value change
-
-$73,074,107
-
Number of buys
-
393
-
Number of sells
-
457
Security key
922042858
Report period
Q1 2016
Institutions
884
Top holders
10
Reporting periods
Holder history for CUSIP 922042858
Recent filing periods:
Top shareholders of VWO - VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF (VWO) as of Q1 2016
As of 31 Mar 2016,
VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF (VWO) was held by
884 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
587,739,064 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, Bridgewater Associates, LP, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Windhaven Investment Management, Inc., WEALTHFRONT INC, NORTHERN TRUST CORP, and UBS Group AG.
This page lists
885
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q1 2016 vs Q4 2015 Across Filers
| Investor |
Q4 2015 Shares |
Q1 2016 Shares |
Share Diff |
Share Chg % |
Q4 2015 Value $ |
Q1 2016 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.